Genetic chaos in aggressive cancer
11 – 20 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Methylation and copy number profiling : emerging tools to differentiate osteoblastoma from malignant mimics?
- Contribution to journal › Article
-
Mark
Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor
- Contribution to journal › Article
-
Mark
Aquaglyceroporins and orthodox aquaporins in human adipocytes
- Contribution to journal › Article
-
Mark
Amplification of ERBB2 (HER2) in embryonal rhabdomyosarcoma : A potential treatment target in rare cases?
- Contribution to journal › Article
- 2020
-
Mark
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma
- Contribution to journal › Article
-
Mark
Genomic and Transcriptomic Analyses of Osteogenic Tumours of Bone
(2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking
- Contribution to journal › Article
-
Mark
Clonal competition within complex evolutionary hierarchies shapes AML over time
- Contribution to journal › Article
-
Mark
PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells
- Contribution to journal › Article
- 2019
-
Mark
Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion
- Contribution to journal › Article
